Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for chemotherapy-induced thrombocytopenia in children with acute lymphoblastic leukemia
ChiCTR-IPR-15006071Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Mar 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human thrombopoietin in Thrombocytopenia (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Platelet count. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on ChiCTR-IPR-15006071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006071.